ClinicalTrials.gg
Drug

BAY987517 clinical trials

Also written BAY987517.

studies test it
35
open now
0
in phase 3
0
first study started
2015

How each study uses BAY987517 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Coppertone (BAY987517)
9
Coppertone (BAY 987517)
7

Development codes

BAY987517
19

Studies by the year they started

35 studies that test it; most in 2016 (18)

Studies that test BAY987517, by start year
YearStudies
201514
201618
20173

By phase

A phase 1/2 study counts in both.

No phase
35

Who runs them

Industry 35 · Other 0

Bayer (35)

Studies

Open first, then newest update. How each study uses BAY987517 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 35

See all 35 studies that test BAY987517 →